Advertisement
OGI vs TLRY
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OGI is a Buy and TLRY is a Hold.
OGI's RSI Indicator climbs out of oversold territory
The RSI Oscillator for OGI moved out of oversold territory on October 15, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 36 similar instances when the indicator left oversold territory. In 33 of the 36 cases the stock moved higher. This puts the odds of a move higher at 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 26, 2026. You may want to consider a long position or call options on OGI as a result. In 73 of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 78%.
The Moving Average Convergence Divergence (MACD) for OGI just turned positive on October 20, 2026. Looking at past instances where OGI's MACD turned positive, the stock continued to rise in 40 of 45 cases over the following month. The odds of a continued upward trend are 89%.
Following a +2.27% 3-day Advance, the price is estimated to grow further. Considering data from situations where OGI advanced for three days, in 169 of 214 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
OGI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
OGI moved below its 50-day moving average on September 28, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where OGI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.
The Aroon Indicator for OGI entered a downward trend on October 26, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 37 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.277) is normal, around the industry mean (8.542). P/E Ratio (1.527) is within average values for comparable stocks, (-1.854). Projected Growth (PEG Ratio) (0.030) is also within normal values, averaging (2.152). Dividend Yield (0.000) settles around the average of (0.046) among similar stocks. P/S Ratio (0.650) is also within normal values, averaging (178.797).
The Tickeron SMR rating for this company is 46 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 76 (best 1 - 100 worst), indicating slightly worse than average price growth. OGI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OGI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
TLRY in upward trend: price may jump up because it broke its lower Bollinger Band on September 30, 2026
TLRY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 30 of 35 cases where TLRY's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 86%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 14 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 22 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +4.71% 3-day Advance, the price is estimated to grow further. Considering data from situations where TLRY advanced for three days, in 166 of 208 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on September 28, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on TLRY as a result. In 72 of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for TLRY turned negative on September 29, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 40 similar instances when the indicator turned negative. In 36 of the 40 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TLRY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for TLRY entered a downward trend on October 30, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 12 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 23 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.220) is normal, around the industry mean (8.346). P/E Ratio (-2.321) is within average values for comparable stocks, (-1.638). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.152). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (0.481) is also within normal values, averaging (178.797).
The Tickeron Price Growth Rating for this company is 91 (best 1 - 100 worst), indicating slightly worse than average price growth. TLRY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TLRY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
OGI | TLRY | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 4 | 55 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 37 Fair valued | 23 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 46 | 93 | |
PRICE GROWTH RATING 1..100 | 76 | 91 | |
P/E GROWTH RATING 1..100 | 97 | 12 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
TLRY's Valuation (23) in the Biotechnology industry is in the same range as OGI (37) in the null industry. This means that TLRY’s stock grew similarly to OGI’s over the last 12 months.
TLRY's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as OGI (100) in the null industry. This means that TLRY’s stock grew similarly to OGI’s over the last 12 months.
OGI's SMR Rating (46) in the null industry is somewhat better than the same rating for TLRY (93) in the Biotechnology industry. This means that OGI’s stock grew somewhat faster than TLRY’s over the last 12 months.
OGI's Price Growth Rating (76) in the null industry is in the same range as TLRY (91) in the Biotechnology industry. This means that OGI’s stock grew similarly to TLRY’s over the last 12 months.
TLRY's P/E Growth Rating (12) in the Biotechnology industry is significantly better than the same rating for OGI (97) in the null industry. This means that TLRY’s stock grew significantly faster than OGI’s over the last 12 months.
| OGI | TLRY | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 90% | 1 day ago 82% |
| Stochastic ODDS (%) | 2 days ago 88% | 1 day ago 83% |
| Momentum ODDS (%) | 2 days ago 78% | 3 days ago 90% |
| MACD ODDS (%) | 2 days ago 89% | 2 days ago 90% |
| TrendWeek ODDS (%) | 2 days ago 80% | 1 day ago 90% |
| TrendMonth ODDS (%) | 2 days ago 84% | 1 day ago 89% |
| Advances ODDS (%) | 2 days ago 79% | 25 days ago 80% |
| Declines ODDS (%) | 8 days ago 85% | 1 day ago 90% |
| BollingerBands ODDS (%) | 2 days ago 85% | 1 day ago 86% |
| Aroon ODDS (%) | 2 days ago 84% | 1 day ago 85% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
OGI’s FA Score shows that 0 FA rating(s) are green while TLRY’s FA Score has 2 green FA rating(s).
- OGI’s FA Score: 0 green, 5 red.
- TLRY’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
OGI’s TA Score shows that 5 TA indicator(s) are bullish while TLRY’s TA Score has 4 bullish TA indicator(s).
- OGI’s TA Score: 5 bullish, 4 bearish.
- TLRY’s TA Score: 4 bullish, 4 bearish.
Price Growth
OGI (@Pharmaceuticals: Generic) experienced а +0.74% price change this week, while TLRY (@Pharmaceuticals: Generic) price change was -9.96% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.14%. For the same industry, the average monthly price growth was -9.43%, and the average quarterly price growth was +3.28%.
Reported Earning Dates
OGI is expected to report earnings on Dec 15, 2026.
Industries' Descriptions
@Pharmaceuticals: Generic (-0.14% weekly)A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.
Advertisement
OGI and
Correlation & Price change
A.I.dvisor indicates that over the last year, OGI has been closely correlated with SNDL. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if OGI jumps, then SNDL could also see price increases.
| Ticker / NAME | Correlation To OGI | 1D Price Change % | ||
|---|---|---|---|---|
| OGI | 100% | -2.85% | ||
| SNDL - OGI | 67% Closely correlated | -4.62% | ||
| ACB - OGI | 64% Loosely correlated | -0.49% | ||
| CGC - OGI | 58% Loosely correlated | -3.33% | ||
| TLRY - OGI | 50% Loosely correlated | -4.17% | ||
| TRLV - OGI | 49% Loosely correlated | -3.02% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| EPMV | 26.39 | N/A | N/A |
| Harbor Mid Cap Value ETF | |||
| WCME | 17.48 | -0.39 | -2.18% |
| First Trust WCM Developing World Equity ETF (WCME) | |||
| OAEM | 45.20 | -1.40 | -3.00% |
| OneAscent Enhanced Small and Mid Cap ETF Institutional Shs OneAscent Emerging Markets Fund (OAEM) | |||
| CLOU | 28.02 | -1.22 | -4.17% |
| Global X Cloud Computing ETF (CLOU) | |||
| USD | 69.87 | -10.26 | -12.80% |
| ProShares Ultra Semiconductors (USD) | |||